68 Einträge gefunden

1. Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer:AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial

   1. Pfisterer, Jacobus
   2. Joly, Florence
   3. Kristensen, Gunnar
   4. Rau, Joern
   5. Mahner, Sven
   6. Pautier, Patricia
   7. El-Balat, Ahmed

   2023 - Forschungsinformationssystem des UKE
2. MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients

   1. Huebner, Hanna
   2. Häberle, Lothar
   3. Müller, Volkmar
   4. Schrader, Iris
   5. Lorenz, Ralf
   6. Forstbauer, Helmut
   7. Fink, Visnja

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell Cancer

   1. Burandt, Eike
   2. Blessin, Niclas C
   3. Rolschewski, Ann-Christin
   4. Lutz, Florian
   5. Mandelkow, Tim
   6. Yang, Cheng
   7. Bady, Elena

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer-A Study of the OVCAD Consortium

   1. Obermayr, Eva
   2. Reiner, Angelika
   3. Brandt, Burkhard
   4. Braicu, Elena Ioana
   5. Reinthaller, Alexander
   6. Loverix, Liselore
   7. Concin, Nicole

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Asbestos Exposure and Ovarian Cancer - a Gynaecological Occupational Disease. Background, Mandatory Notification, Practical Approach

   1. Nowak, Dennis
   2. Schmalfeldt, Barbara
   3. Tannapfel, Andrea
   4. Mahner, Sven

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer-A Study of the OVCAD Consortium

   1. Obermayr, Eva
   2. Braicu, Elena Ioana
   3. Polterauer, Stephan
   4. Loverix, Liselore
   5. Concin, Nicole
   6. Woelber, Linn
   7. Mahner, Sven

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Prognostic role of thrombocytosis in recurrent ovarian cancer:a pooled analysis of the AGO Study Group

   1. Canzler, Ulrich
   2. Lück, Hans-Joachim
   3. Neuser, Petra
   4. Sehouli, Jalid
   5. Burges, Alexander
   6. Harter, Philipp
   7. Schmalfeldt, Barbara

   2020 - Forschungsinformationssystem des UKE
8. Sexual activity and quality of life in patients after treatment for breast and ovarian cancer

   1. Mayer, Sebastian
   2. Iborra, Severine
   3. Grimm, Donata
   4. Steinsiek, Lisa
   5. Mahner, Sven
   6. Bossart, Michaela
   7. Woelber, Linn

   2019 - Forschungsinformationssystem des UKE
9. Glucocorticoid receptors α and β are modulated sex specifically in human placentas of intrauterine growth restriction (IUGR)

   1. Hutter, Stefan
   2. Hepp, Paula
   3. Hofmann, Simone
   4. Kuhn, Christina
   5. Messner, Julia
   6. Andergassen, Ulrich
   7. Mayr, Doris

   2019 - Forschungsinformationssystem des UKE
10. Correlation of Isotope Count With Sentinel Node Positivity in Vulvar Cancer

    1. Wölber, Linn
    2. Joosse, Simon
    3. Grimm, Donata
    4. Mathey, Sabrina
    5. Mahner, Sven
    6. Burandt, Eike Christian
    7. Klutmann, Susanne

    2018 - Forschungsinformationssystem des UKE
11. No need for NMDA receptor antibody screening in neurologically asymptomatic patients with ovarian teratomas

    1. Trillsch, Fabian
    2. Eichhorn, Peter
    3. Oliveira-Ferrer, Leticia
    4. Kuempfel, Tania
    5. Burges, Alexander
    6. Mahner, Sven
    7. Havla, Joachim

    2018 - Forschungsinformationssystem des UKE
12. Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer

    1. Prieske, Katharina
    2. Prieske, Stefan
    3. Joosse, Simon A
    4. Trillsch, Fabian
    5. Grimm, Donata
    6. Burandt, Eike
    7. Mahner, Sven

    2017 - Forschungsinformationssystem des UKE
13. European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer

    1. Oonk, Maaike H M
    2. Planchamp, François
    3. Baldwin, Peter
    4. Bidzinski, Mariusz
    5. Brännström, Mats
    6. Landoni, Fabio
    7. Mahner, Sven

    2017 - Forschungsinformationssystem des UKE
14. VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients

    1. Kuerti, Sascha
    2. Oliveira-Ferrer, Leticia
    3. Milde-Langosch, Karin
    4. Schmalfeldt, Barbara
    5. Legler, Karen
    6. Woelber, Linn
    7. Prieske, Katharina

    2017 - Forschungsinformationssystem des UKE
15. E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer

    1. Trillsch, Fabian
    2. Kuerti, Sascha
    3. zu Eulenburg, Christine
    4. Burandt, Eike
    5. Woelber, Linn
    6. Prieske, Katharina
    7. Eylmann, Kathrin

    2016 - Forschungsinformationssystem des UKE
16. Corrigendum to "Borderline tumours of the ovary A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie AGO Study Group" [Eur J Cancer 49 (2013) 1905-1914]

    1. du Bois, Andreas
    2. Ewald-Riegler, Nina
    3. de Gregorio, Nikolaus
    4. Reuss, Alexander
    5. Mahner, Sven
    6. Fotopoulou, Christina
    7. Kommoss, Friedrich

    2016 - Forschungsinformationssystem des UKE
17. Placental Expression Patterns of Galectin-1, Galectin-2, Galectin-3 and Galectin-13 in Cases of Intrauterine Growth Restriction (IUGR)

    1. Hutter, Stefan
    2. Knabl, Julia
    3. Andergassen, Ulrich
    4. Hofmann, Simone
    5. Kuhn, Christina
    6. Mahner, Sven
    7. Arck, Petra

    2016 - Forschungsinformationssystem des UKE - frei zugänglich
18. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer

    1. Claussen, Carlota
    2. Rausch, Alma-Verena
    3. Lezius, Susanne
    4. Amirkhosravi, Ali
    5. Davila, Monica
    6. Francis, John L
    7. Hisada, Yohei M

    2016 - Forschungsinformationssystem des UKE
19. The Risk of Contralateral Non-sentinel Metastasis in Patients with Primary Vulvar Cancer and Unilaterally Positive Sentinel Node

    1. Woelber, Linn
    2. Eulenburg, Christine
    3. Grimm, Donata
    4. Trillsch, Fabian
    5. Bohlmann, Inga
    6. Burandt, Eike
    7. Dieckmann, Jan

    2016 - Forschungsinformationssystem des UKE
20. In vitro study comparing the efficacy of the water-soluble HSP90 inhibitors, 17-AEPGA and 17-DMAG, with that of the non‑water-soluble HSP90 inhibitor, 17-AAG, in breast cancer cell lines

    1. Ghadban, Tarik
    2. Jessen, André
    3. Reeh, Matthias
    4. Dibbern, Judith L
    5. Mahner, Sven
    6. Mueller, Volkmar
    7. Wellner, Ulrich F

    2016 - Forschungsinformationssystem des UKE